PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

30.30$ -0.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PBLS
Line item	2024	2025
Revenue	0.00	0.00
Research & Development	52.13	62.07
Selling, General & Administrative	13.08	13.10
Total Operating Expenses	65.20	75.17
Operating Income	-65.20	-75.17
Interest Expense	0.77	0.75
Pre-Tax Income	-60.96	-72.11
Net Income	-60.96	-72.11
EBITDA	-59.11	-70.12

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.